Sean P. Nolan

Sean Nolan, 51, is an accomplished senior executive with more than 28 years of biopharmaceutical experience. He served as Chief Executive Officer and President at AveXis, Inc. (formerly NASDAQ: AVXS), a clinical-stage gene therapy company, from 2015 to 2018, successfully growing the company from four employees to a publicly listed company which was acquired by Novartis for $8.7 billion in 2018. Mr. Nolan is Chairman of a gene therapy company, Encoded Therapeutics, Inc., and Executive Chairman of Istari Oncology, Inc. He is also a member of the Board of Directors of Aquinox Pharmaceuticals Inc. (Nasdaq: AQXP), a clinical-stage pharmaceutical company, where he is serves on the Audit Committee and is Chairman of the Nominating and Governance Committee.